Evidence map›Paper›PMID 27927229›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2016

Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience.

Felipe Couñago, Manuel Recio, Antonio Maldonado, Elia Del Cerro, Ana Aurora Díaz-Gavela, Israel J Thuissard, David Sanz-Rosa, Francisco José Marcos, Karmele Olaciregui, María Mateo and 1 more

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Diagnostic performance ofClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2019
    Observational
  3. Review
  4. Multiparametric magnetic resonance imaging-guided salvage radiotherapy in prostate cancer.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Felipe CouñagoDepartment of Radiation Oncology, Hospital Universitario Quiron Madrid, Calle Diego de Velazquez, 1, 28223, Pozuelo de Alarcón, Madrid, Spain. fcounago@gmail.com.ORCID http://orcid.org/0000-0001-7233-0234
Manuel RecioDepartment of Radiology, Hospital Universitario Quiron, Madrid, Spain.
Antonio MaldonadoDepartment of Nuclear Medicine, Hospital Universitario Quiron, Madrid, Spain.
Elia Del CerroDepartment of Radiation Oncology, Hospital Universitario Quiron Madrid, Calle Diego de Velazquez, 1, 28223, Pozuelo de Alarcón, Madrid, Spain.
Ana Aurora Díaz-GavelaDepartment of Radiation Oncology, Hospital Universitario Quiron Madrid, Calle Diego de Velazquez, 1, 28223, Pozuelo de Alarcón, Madrid, Spain.
Israel J ThuissardSchool of Doctoral Studies and Research, Universidad Europea de Madrid, Madrid, Spain.
David Sanz-RosaSchool of Doctoral Studies and Research, Universidad Europea de Madrid, Madrid, Spain.
Francisco José MarcosDepartment of Radiation Oncology, Hospital Universitario Quiron Madrid, Calle Diego de Velazquez, 1, 28223, Pozuelo de Alarcón, Madrid, Spain.
Karmele OlacireguiClinical Department, School of Biomedical Sciences, Universidad Europea de Madrid, Madrid, Spain.
María MateoHospital Universitario Quiron, Madrid, Spain.
Laura CerezoDepartment of Radiation Oncology, Hospital Universitario La Princesa, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo evaluate and compare the utility of 18F-fluorocholine (18F-CH) PET/CT versus 3-Tesla multiparametric MRI (mpMRI) without endorectal coil to detect tumor recurrences in patients with biochemical relapse following radical prostatectomy (RP). Secondarily, to identify possible prognostic variables associated with mpMRI and 18F-CH PET/CT findings.

methodsRetrospective study of 38 patients who developed biochemical recurrence after RP between the years 2011 and 2015 at our institution. PET/CT and mpMRI were both performed within 30 days of each other in all patients. The PET/CT was reviewed by a nuclear medicine specialist while the mpMRI was assessed by a radiologist, both of whom were blinded to outcomes.

resultsThe median prostate-specific antigen (PSA) value pre-MRI/PET-CT was 0.9 ng/mL (interquartile range 0.4-2.2 ng/mL). There were no differences in the detection rate between 18F-CH PET/CT and mpMRI for local recurrence (LR), lymph node recurrence (LNR) and bone metastases (BM). Separately, mpMRI and 18F-CH PET/CT were positive for recurrence in 55.2% and 52.6% of cases, respectively, and in 65.7% of cases when findings from both modalities were considered together. The detection of LR was better with combined mpMRI and choline PET/CT versus choline PET/CT alone (34.2% vs 18.4%, p = 0.04). Salvage treatment was modified in 22 patients (57.8%) based on the imaging findings. PSA values on the day of biochemical failure were significantly associated with mpMRI positivity (adjusted odds ratio (OR): 30.9; 95% confidence interval (CI): 1.5-635.8). Gleason score > 7 was significantly associated with PET/CT positivity (OR: 13.9; 95% CI: 1.5-125.6). A significant association was found between PSA doubling time (PSADT) (OR: 1.3; 95% CI: 1.0-1.7), T stage (OR: 21.1; 95% CI: 1.6-272.1), and LR.

conclusionsMultiparametric MRI and 18F-CH PET/CT yield similar detection rates for LR, LNR and pelvic BM. The combination of both imaging techniques provides a better LR detection versus choline PET/CT alone. The initially planned salvage treatment was modified in 57.8% of patients due to imaging findings. In addition to PSA values, Gleason score, T stage, and PSADT may provide valuable data to identify those patients that are most likely to benefit from undergoing both imaging procedures.

Indexed as

Magnetic Resonance ImagingPositron Emission Tomography Computed TomographyAgedCholineHumansMaleMiddle AgedNeoplasm Recurrence, LocalProstatectomyProstatic NeoplasmsRadiopharmaceuticalsCholinefluoromethylcholineRadiopharmaceuticals18F-Choline PET/CTBiochemical failureMultiparametric MRIProstate cancerRadical prostatectomy

Identifiers

PMID27927229
PMCPMC5142428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.